País: Austràlia
Idioma: anglès
Font: Department of Health (Therapeutic Goods Administration)
ipratropium bromide monohydrate, Quantity: 522 microgram/mL (Equivalent: ipratropium bromide, Qty 500 microgram/mL)
Boehringer Ingelheim Pty Ltd
Inhalation, conventional
Excipient Ingredients: sodium chloride; hydrochloric acid; purified water
Inhalation
30 x 1mL ampoules, 10 x 1mL ampoules
(S4) Prescription Only Medicine
Moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. Administration of Atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.
Visual Identification: Clear, colourless or almost colourless liquid, free from suspending particles and filled into polyethylene ampoules.; Container Type: Ampoule; Container Material: PE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1996-12-16
ATROVENT UDVS CMI0119-05 1 ATROVENT ® UDV _ATROVENT 250 ΜG/1 ML AND ATROVENT ADULT 500 ΜG/1 ML UNIT DOSE VIAL (UDV) _ _ipratropium bromide monohydrate _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Atrovent UDV. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor or pharmacist has weighed the risks of you using Atrovent UDV against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. This leaflet was last updated on the date at the end of this leaflet. More recent information may be available. The latest Consumer Medicine Information is available from your pharmacist, doctor, or from www.medicines.org.au and may contain important information about the medicine and its use of which you should be aware. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT ATROVENT UDV IS USED FOR Atrovent UDV is used to treat: asthma chronic obstructive bronchitis people who have difficulty breathing during or after surgery using assisted ventilation. Asthma is a disease where the lining of the lungs becomes inflamed (red and swollen), making it difficult to breathe. This may be due to an allergy to house dust mites, smoke or other irritants. Chronic obstructive bronchitis is a lung condition that can cause difficulty in breathing, wheeziness and constant coughing. Atrovent UDV contains the active ingredient ipratropium bromide monohydrate. It belongs to a group of medicines called anticholinergic bronchodilators. Atrovent UDV opens up the air passages in people suffering from asthma, chronic bronchitis and difficulty breathing during or after surgery. It begins to act quickly after use but may take up to 2 hours to give maximum benefit. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY ATROVENT UDV HAS BEEN PRESCRIBED FOR YOU. Your doctor may have Llegiu el document complet
ATROVENT Inhalation Solutions PI0059-14 1 AUSTRALIAN PRODUCT INFORMATION – ATROVENT ® (IPRATROPIUM BROMIDE MONOHYDRATE) INHALATION SOLUTION 1. NAME OF THE MEDICINE ipratropium bromide monohydrate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 mL of ATROVENT Inhalation Solution contains ipratropium bromide monohydrate 261 micrograms (equivalent to 250 micrograms ipratropium bromide). Each 1 mL of ATROVENT UNIT DOSE VIAL (UDV) contains ipratropium bromide monohydrate 261 micrograms (equivalent to 250 micrograms ipratropium bromide). Each 1 mL of ATROVENT ADULT UNIT DOSE VIALS (UDV) contains ipratropium bromide monohydrate 522 micrograms (equivalent to 500 micrograms ipratropium bromide). Excipients with known effect: ATROVENT Inhalation Solution contains 0.1 mg benzalkonium chloride in each mL and disodium edetate. For the full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM ATROVENT is an inhalation solution. ATROVENT Inhalation Solution - clear, colourless or almost colourless liquid, free from suspended particles in multidose bottle. Contains benzalkonium chloride as the preservative. ATROVENT UDV - preservative free, clear, colourless or almost colourless liquid, free from suspended particles. ATROVENT ADULT UDV - preservative free, clear, colourless or almost colourless liquid, free from suspended particles. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. Administration of ATROVENT via a nebuliser is intended for those patients who cannot use a metered dose aerosol. 4.2 DOSE AND METHOD OF ADMINISTRATION ATROVENT solution can be administered via a range of commercially available nebulising devices. Where wall oxygen is available, solutions are best administered at a flow rate of 6-8 litres per minute. Dosage is dependent on the mo Llegiu el document complet